心臓再同期療法(CRT)の世界市場予測(~2024年)

◆英語タイトル:Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024
◆商品コード:MD-7035
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2019年4月1日
◆ページ数:108
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、心臓再同期療法(CRT)の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品タイプ別(CRT除細動器・CRTペースメーカー)分析、エンドユーザー別(病院・心臓センター、外来外科センター)分析、心臓再同期療法(CRT)の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

“The CRT market is projected to grow at a CAGR of 4.4% during the forecast period (2019–2024).”The CRT market is projected to reach USD 5.1 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 4.4%. The growth of the CRT market is mainly driven by the increasing incidence of target disease and growth in the geriatric population. Rising investments and support, along with technological advancements, are also contributing to the growth of the market. However, unfavorable healthcare reforms in the US are expected to limit market growth to a certain extent.

“By product type, the cardiac resynchronization therapy defibrillators (CRT-D) segment accounted for the largest share of the market in 2018.”

On the basis of product type, the CRT market is segmented into cardiac resynchronization therapy defibrillators (CRT-Ds) and cardiac resynchronization therapy pacemakers (CRT-Ps). The CRT-Ds segment accounted for the largest share of the market in 2018. This is majorly attributed to the increasing acceptance of CRT-Ds over pacemakers and the launch of technologically advanced devices. Furthermore, growth in this market segment is largely driven by the increasing incidence of target diseases.

“By end user, the hospitals & cardiac centers segment is expected to dominate the CRT market during the forecast period.”

On the basis of end user, the CRT market is segmented into the hospitals & cardiac centers and ambulatory surgery centers. Hospitals & cardiac centers accounted for the largest share of the market in 2018. The increasing prevalence of CVD, rising number of surgical procedures performed, favorable reimbursement scenario, and the increasing number of critical care and intensive care units are some of the key factors driving the growth of the hospitals & cardiac centers segment.

“APAC is expected to witness the highest growth during the forecast period.”
The Asia Pacific region is projected to register the highest growth rate in the CRT systems market during the forecast period. Favorable reimbursement scenario in Japan, the rising geriatric population in China, rising incidence of CVDs, improving healthcare infrastructure, growing middle-class population, and rising disposable income levels in India are some of the key factors driving the growth of the CRT systems market in the Asia Pacific.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–55%, Tier 2–25%, and Tier 3–20%
• By Designation: C-level–43%, Director-level–32%, and Others–25%
• By Region: North America–38%, Europe–23%, Asia Pacific–29%, Rest of World–10%

The prominent players in the CRT market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).

Research Coverage:
The report analyzes the market for various cardiac resynchronization therapy (CRT) systems and their adoption pattern. It aims at estimating the market size and future growth potential of the CRT market and the different segments. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the CRT market
• Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the CRT market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global CRT market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of the leading players in the CRT market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
1.3.2 YEARS CONSIDERED FOR THE STUDY 13
1.4 CURRENCY 14
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 RESEARCH DATA 15
2.1.1 SECONDARY DATA 17
2.1.1.1 Key data from secondary sources 17
2.1.2 PRIMARY DATA 18
2.1.2.1 Key data from primary sources 19
2.1.2.2 Key industry insights 20
2.2 MARKET SIZE ESTIMATION 20
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION 22
2.3 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET OVERVIEW 27
4.2 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY TYPE, 2018 28
4.3 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018 29
4.4 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: GEOGRAPHIC SNAPSHOT 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.2.1 DRIVERS 32
5.2.1.1 Increasing incidence of target diseases 32
5.2.1.2 Growth in the geriatric population 32
5.2.1.3 Growing investments, funds, and grants 33
5.2.1.4 Technological advancements 34

5.2.1.5 MRI-safe device technology 34
5.2.1.6 Wireless CRT 34
5.2.2 RESTRAINTS 34
5.2.2.1 Unfavorable healthcare reforms in the US 34
5.2.3 OPPORTUNITIES 35
5.2.3.1 Emerging markets 35
5.2.4 CHALLENGES 35
5.2.4.1 Shortage of skilled cardiac surgeons 35
5.2.4.2 Product recalls 36
5.2.4.3 Battery life and device replacement cost 37
6 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE 38
6.1 INTRODUCTION 39
6.2 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS 40
6.2.1 CRT – DEFIBRILLATORS ACCOUNTED FOR THE LARGEST SHARE OF
THE CRT SYSTEMS MARKET IN 2018 40
6.3 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS 41
6.3.1 THE CRT – PACEMAKERS MARKET WILL GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 41
7 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER 43
7.1 INTRODUCTION 44
7.2 HOSPITALS & CARDIAC CENTERS 45
7.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE THE END-USER MARKET 45
7.3 AMBULATORY SURGERY CENTERS 46
7.3.1 INCREASING NUMBER OF CENTERS IN THE US TO DRIVE THE ADOPTION
OF CRT DEVICES 46
8 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION 47
8.1 INTRODUCTION 48
8.2 NORTH AMERICA 50
8.2.1 US 53
8.2.1.1 Technological advancements—A key factor driving market growth 53
8.2.2 CANADA 55
8.2.2.1 Growing focus of government and private organizations on providing research funding is expected to drive the market in Canada 55
8.3 EUROPE 57
8.3.1 GERMANY 61
8.3.1.1 Favorable healthcare expenditure and growing use of CRT devices to drive market growth 61
8.3.2 UK 63
8.3.2.1 Increasing geriatric population and increasing use of CRT devices to drive market growth 63

8.3.3 FRANCE 65
8.3.3.1 Growing use of cardiac resynchronization therapy devices for heart failure to support market growth 65
8.3.4 ITALY 66
8.3.4.1 Increasing incidence of CVDs to drive the adoption of cardiac resynchronization therapy devices in the country 66
8.3.5 REST OF EUROPE 67
8.4 ASIA PACIFIC 69
8.4.1 JAPAN 72
8.4.1.1 Favourable reimbursement policy to support market growth 72
8.4.2 CHINA 74
8.4.2.1 Growing geriatric population to drive the market for cardiac resynchronization therapy systems 74
8.4.3 INDIA 75
8.4.3.1 Growing middle-class population & rising disposable income levels are supporting the growth of the CRT systems market in India 75
8.4.4 REST OF ASIA PACIFIC 76
8.5 REST OF THE WORLD 78
9 COMPETITIVE LANDSCAPE 82
9.1 OVERVIEW 82
9.2 MARKET SHARE ANALYSIS 82
9.2.1 MEDTRONIC 83
9.2.2 ABBOTT LABORATORIES 83
9.2.3 BOSTON SCIENTIFIC CORPORATION 83
9.3 COMPETITIVE SCENARIO 83
9.3.1 PRODUCT LAUNCHES AND APPROVALS 84
9.3.2 EXPANSIONS 84
9.3.3 ACQUISITIONS, 2017 – 2018 85
10 COMPANY PROFILES 86
(Business Overview, Products Offered, Recent Developments, and MnM View)*
10.1 MEDTRONIC, PLC. 86
10.2 ABBOTT LABORATORIES 89
10.3 BOSTON SCIENTIFIC CORPORATION 92
10.4 BIOTRONIK 95
10.5 MEDICO S.P.A. 97
10.6 MICROPORT SCIENTIFIC CORPORATION 98
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

11 APPENDIX 100
11.1 DISCUSSION GUIDE 100
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 104
11.3 AVAILABLE CUSTOMIZATIONS 106
11.4 RELATED REPORTS 106
11.5 AUTHOR DETAILS 107

LIST OF TABLES

TABLE 1 POPULATION STATISTICS, 2015 VS 2030 VS 2050 (MILLION INDIVIDUALS) 33
TABLE 2 LIST OF PRODUCT RECALLS 36
TABLE 3 BATTERY SURVIVAL RATE BY DEVICE MANUFACTURER 37
TABLE 4 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE,
2017–2024 (USD MILLION) 39
TABLE 5 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017–2024 (USD MILLION) 40
TABLE 6 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017–2024 (UNITS) 41
TABLE 7 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2017–2024 (USD MILLION) 42
TABLE 8 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2017–2024 (UNITS) 42
TABLE 9 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION) 44
TABLE 10 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 11 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2017–2024 (USD MILLION) 46
TABLE 12 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION,
2017–2024 (USD MILLION) 49
TABLE 13 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION,
2017–2024 (UNITS) 49
TABLE 14 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 51
TABLE 15 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 52
TABLE 16 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 17 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 18 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 53
TABLE 19 CLINICAL TRIALS RELATED TO CARDIAC RESYNCHRONIZATION THERAPY DEVICES 54
TABLE 20 US: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE,
2017–2024 (USD MILLION) 55
TABLE 21 US: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION) 55
TABLE 22 CANADA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 56
TABLE 23 CANADA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 57
TABLE 24 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 25 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 60
TABLE 26 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 27 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 61
TABLE 28 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 61
TABLE 29 GERMANY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 30 GERMANY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 63
TABLE 31 RESEARCH STUDIES RELATED TO CRT DEVICES IN THE UK 64
TABLE 32 UK: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE,
2017–2024 (USD MILLION) 64
TABLE 33 UK: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION) 65
TABLE 34 FRANCE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 66
TABLE 35 FRANCE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 66
TABLE 36 ITALY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 67
TABLE 37 ITALY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION) 67
TABLE 38 CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY 68
TABLE 39 ROE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 68
TABLE 40 ROE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION) 68
TABLE 41 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 71
TABLE 42 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 71
TABLE 43 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 71
TABLE 44 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 72
TABLE 45 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 72
TABLE 46 JAPAN: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 73
TABLE 47 JAPAN: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 73
TABLE 48 CHINA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 74
TABLE 49 CHINA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 75
TABLE 50 INDIA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 76
TABLE 51 INDIA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 76
TABLE 52 CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY 77
TABLE 53 ROAPAC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 77
TABLE 54 ROAPAC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET,
BY END USER, 2017–2024 (USD MILLION) 77
TABLE 55 CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY 79
TABLE 56 ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION) 80
TABLE 57 ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION) 81
TABLE 58 PRODUCT LAUNCHES AND APPROVALS, 2017 - 2018 84
TABLE 59 EXPANSIONS, 2016 84




LIST OF FIGURES

FIGURE 1 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SEGMENTATION 13
FIGURE 2 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET:
RESEARCH METHODOLOGY 15
FIGURE 3 RESEARCH DESIGN 16
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 19
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
FIGURE 7 DATA TRIANGULATION METHODOLOGY 22
FIGURE 8 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018 24
FIGURE 9 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2018 25
FIGURE 10 GEOGRAPHIC SNAPSHOT: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, 2018 26
FIGURE 11 INCREASING INCIDENCE TARGET DISEASE TO DRIVE THE GROWTH OF
THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET 27
FIGURE 12 DEFIBRILLATORS TO DOMINATE THE NORTH AMERICAN MARKET DURING
THE FORECAST PERIOD 28
FIGURE 13 CRT - DEFIBRILLATORS TO DOMINATE THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET DURING THE FORECAST PERIOD 29
FIGURE 14 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 30
FIGURE 15 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET:
DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 31
FIGURE 16 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 39
FIGURE 17 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER,
2019 VS. 2024 (USD MILLION) 44
FIGURE 18 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION,
2019 VS. 2024 48
FIGURE 19 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS
MARKET SNAPSHOT 51
FIGURE 20 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT 59
FIGURE 21 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS
MARKET SNAPSHOT 70
FIGURE 22 ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT 80
FIGURE 23 MARKET SHARE ANALYSIS BY KEY PLAYERS (2015–2018) 82
FIGURE 24 MEDTRONIC, PLC: COMPANY SNAPSHOT (2017) 86
FIGURE 25 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018) 89
FIGURE 26 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2017) 92
FIGURE 27 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2017) 98



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心臓再同期療法(CRT)の世界市場予測(~2024年)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆